Sudden arrhythmic death in patients with syncope and implantable cardiac monitor
In patients with unexplained syncope, an implantable cardiac monitor (ICM) is an effective tool to guide treatment decisions.1 If the ICM detects an arrhythmia associated with symptoms, implantation of a permanent pacemaker for bradycardic syncope or an implantable cardioverter-defibrillator for ventricular arrhythmias is indicated.2,3 However, in the absence of symptoms, the case can be less clear despite findings of significant arrhythmias. Specifically, the evidence underlying guideline recommendation of permanent pacing for >6 seconds of asymptomatic sinus pause or atrioventricular (AV) block remain unclear.
Authors
- Roland Papp (ORCID: https://orcid.org/0000-0001-6701-2362)
- Dennis H. Lau (ORCID: https://orcid.org/0000-0001-7753-1318)
- Alessandro Cuneo (ORCID: https://orcid.org/0000-0003-1443-2341)
- Pilar Cabanas Grandío
- Giovanni Bisignani (ORCID: https://orcid.org/0000-0001-9704-6715)
- Jürgen Schrader
- Bertrand Pierre (ORCID: https://orcid.org/0000-0003-3142-3770)
Institutions
- Semmelweis University (HU)
- Université de Tours (FR)
- Royal Adelaide Hospital (AU)
- University Hospital Complex Of Vigo (ES)
- St. Marien Hospital (DE)
- Biotronik (Germany) (DE)
Publication Details
- Journal
- Heart Rhythm O2
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.hroo.2024.09.002
- Primary Topic
- Cardiovascular Syncope and Autonomic Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation
- Biotronik
- MicroPort